SCHEMBL4714907

SCHEMBL4714907

O=C(O)CC1CN(Cc2ccc(-c3ccccc3CNc3ccccn3)cc2)CCc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 9/20 0.42
ITGAV P06756 9/20 0.42
ITGA2B P08514 4/20 0.42
ITGB5 P18084 4/20 0.42
GRIN1 Q05586 1/20 0.40
GRIN2B Q13224 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
ITGB1 P05556 1/20 0.40
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
MEN1 O00255 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 2/20 0.36
BDKRB1 P46663 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4714911 0.80 CD274 (0.37) ITGB3ITGAVITGA2BITGB5ITGB1
SCHEMBL4715705 0.74 ITGB3 (0.55) ITGB3ITGAVITGA2BITGB5ITGB1
SCHEMBL4718120 0.73 ITGB3 (0.54) ITGB3ITGAVITGA2BITGB5ITGB1
SCHEMBL4716885 0.72 SIGMAR1 (0.48) GRIN1GRIN2BSIGMAR1DRD4MEN1
SCHEMBL4718124 0.71 ITGB3 (0.51) ITGB3ITGAVITGA2BITGB5ITGB1
SCHEMBL14221985 0.70 ITGB3 (0.47) ITGB3ITGAVITGA2BITGB5GRIN2B
SCHEMBL4716846 0.69 ITGB3 (0.51) ITGB3ITGAVITGA2BITGB5ITGB1
SCHEMBL4716833 0.69 ITGB3 (0.56) ITGB3ITGAVITGA2BITGB5ITGB1
SCHEMBL4718116 0.69 ITGB3 (0.53) ITGB3ITGAVITGA2BITGB5ITGB1
SCHEMBL4718667 0.68 ITGB3 (0.51) ITGB3ITGAVITGA2BITGB5ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216230-B1 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS AMGEN INC (US) 2008-04-23 EP disclosed